City Therapeutics (NASDAQ:CTY) Sets New 1-Year Low – Time to Sell?

City Therapeutics, Inc. (NASDAQ:CTY)’s stock price reached a new 52-week low during trading on Monday. The company traded as low as $19.19 and last traded at $21.36, with a volume of 17,035 shares trading hands. The stock had previously closed at $20.71.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of City Therapeutics to a “hold” rating in a report on Saturday, October 24th.

City Therapeutics Stock Down 1.2%

Insider Transactions at City Therapeutics

In other City Therapeutics news, major shareholder Arch Venture Partners Xii, Llc bought 170,000 shares of City Therapeutics stock in a transaction dated Monday, October 19th. The shares were bought at an average price of $18.00 per share, with a total value of $3,060,000.00. Following the purchase, the insider owned 13,692,507 shares of the company’s stock, valued at $246,465,126. This trade represents a 1.26% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Robert Nelsen purchased 170,000 shares of the stock in a transaction dated Monday, October 19th. The shares were acquired at an average price of $18.00 per share, with a total value of $3,060,000.00. Following the transaction, the director owned 13,692,507 shares in the company, valued at $246,465,126. This trade represents a 1.26% increase in their ownership of the stock. The SEC filing for this purchase provides additional information.

About City Therapeutics